Printer Friendly
The Free Library
5,673,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cyanotech Delays First Quarter Fiscal 2007 Financial Results.


KAILUA KONA, Hawaii -- Cyanotech Corporation (Nasdaq:CYAN), a world leader in producing high-value nutrition and health products from microalgae, announced it will file for an extension with the Securities and Exchange Commission of the time to file its Form 10-Q Report for its first quarter fiscal 2007 period ended June 30, 2006. The quarter's results had been scheduled to be announced To be announced (TBA)

A contract for the purchase or sale of an MBS to be delivered at an agreed-upon future date but does not include a specified pool number and number of pools or precise amount to be delivered.
 by news release on August 10, 2006.

During final review of first quarter fiscal 2007 results, a matter emerged involving the company's historical treatment of certain inventory related costs. This requires review and resolution prior to filing the Form 10-Q. The Company now expects to file its Form 10-Q for the first quarter of fiscal 2007 by August 21, 2006.

About Cyanotech -- Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin(R) Natural Astaxanthin and Hawaiian Spirulina spirulina

Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12.
 Pacifica(R) -- all natural, functional nutrients that enhance human health and nutrition. Cyanotech's spirulina, FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 reviewed and accepted as Generally Recognized as Safe Generally Recognized as Safe (GRAS) is a United States of America Food and Drug Administration (FDA) designation that a chemical or substance added to food is considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food  (GRAS GRAS - A public domain graph-oriented database system for software engineering applications from RWTH Aachen. ) for use as a food ingredient, augments energy and immune response. BioAstin's benefits derive from its superior antioxidant activity and from its ability to support and maintain natural inflammatory response, enhancing skin, muscle and joint health. NatuRose(R) Natural Astaxanthin is a natural pigment source that also promotes animal health and nutrition, primarily in aquaculture. Phycobiliproteins are fluorescent pigments used in medical diagnostic testing and research. Cyanotech produces these products from microalgae grown at its 90-acre facility in Hawaii using patented and proprietary technology and distributes them to nutritional supplement, nutraceutical, cosmeceutical, and animal feed makers and marketers in more than 40 countries worldwide. Cyanotech was the first microalgae company in the world to obtain ISO (1) See ISO speed.

(2) (International Organization for Standardization, Geneva, Switzerland, www.iso.ch) An organization that sets international standards, founded in 1946. The U.S. member body is ANSI.
 9001:2000. Visit www.cyanotech.com for more information.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 9, 2006
Words:288
Previous Article:Marie Osmond Serves Cool Treats to Help Kids.
Next Article:NRG Energy Announces Secondary Offering of Common Stock.
Topics:



Related Articles
Cyanotech Reports Third Quarter Fiscal 2001 Financial Results; Initiation of Second Clinical Trial for BioAstin Announced.
Cyanotech Corporation Announces Fiscal Year 2005 Fourth Quarter & Year-End Financial Results Webcast May 16, 2005.
Cyanotech Corporation Reports Fourth Quarter and Fiscal Year-End 2005 Financial Results; Company Reports Net Income of $486,000 for the Fiscal Year...
Cyanotech Corporation Reports First Quarter Fiscal 2006 Financial Results; Reports Net Income of $153,000 on Sales of $3,029,000.
Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results; Reports Sales of $2,517,000, Net Loss of $321,000.
Cyanotech Reports Fourth Quarter and Fiscal 2006 Financial Results; Fiscal Year Sales Down 3%, Fourth Quarter Sales up 27%; Webcast is Scheduled for...
Cyanotech Corporation Announces First Quarter Fiscal 2007 Financial Results Webcast on August 10, 2006.
Cyanotech Continues Delay of First Quarter Fiscal 2007 Financial Results.
Cyanotech Corporation Delays Filing.
Cyanotech Receives Delisting Notice from Nasdaq Due to Late Filing of Form 10-Q, Regains Compliance with Nasdaq Capital Market's Minimum Bid Price...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles